Payden & Rygel’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-31,100
Closed -$10.2M 139
2026
Q1
$10.2M Hold
31,100
0.79% 54
2025
Q4
$10.9M Sell
31,100
-1,200
-4% -$437K 0.76% 49
2025
Q3
$11.9M Sell
32,300
-21,200
-40% -$8.19M 0.99% 48
2025
Q2
$21.2M Hold
53,500
1.75% 18
2025
Q1
$19.9M Buy
53,500
+5,400
+11% +$2.06M 1.71% 19
2024
Q4
$17.3M Sell
48,100
-3,600
-7% -$1.33M 1.49% 24
2024
Q3
$18.7M Buy
51,700
+200
+0.4% +$69K 1.44% 25
2024
Q2
$17.5M Buy
+51,500
New +$17.4M 1.42% 31

Other funds holding SYK

Payden & Rygel's SYK Position: Q2 2026 in Review

Payden & Rygel sold out of Stryker (SYK) in Q2 2026, closing a stake of 31,100 shares — an estimated $10.2M sold.

Payden & Rygel first reported a position in SYK in Q2 2024 and held it in 8 quarters. The position peaked at $21.2M in Q2 2025. 2,259 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Payden & Rygel reported no remaining Stryker position as of Q2 2026 after selling out during the quarter.
  • Payden & Rygel sold 31,100 Stryker shares in Q2 2026, an estimated $10.2M.
  • Payden & Rygel first reported a position in Stryker in Q2 2024 and held it in 8 quarters.
  • Payden & Rygel's Stryker position peaked at $21.2M in Q2 2025.
  • 2,259 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Payden & Rygel's 13F filing for Q2 2026, filed 31 Jul 2026.